key: cord-0861150-j5dadm27 authors: Hartline, Caroll B.; Conner, Ra’Shun L.; James, Scott H.; Potter, Jennifer; Gray, Edward; Estrada, Jose; Tector, Mathew; Tector, A. Joseph; Prichard, Mark N. title: Xenotransplantation panel for the detection of infectious agents in pigs date: 2018-07-01 journal: Xenotransplantation DOI: 10.1111/xen.12427 sha: 29089e5ebd7146e5d7f898eceb38648f7344ec9a doc_id: 861150 cord_uid: j5dadm27 Recent advances in xenotransplantation have produced organs from pigs that are well tolerated in primate models because of genetic changes engineered to delete major antigens from donor animals. To ensure the safety of human transplant recipients, it will be essential to understand both the spectrum of infectious agents in donor pigs and their potential to be transmitted to immunocompromised transplant recipients. Equally important will be the development of new highly sensitive diagnostic methods for use in the detection of these agents in donor animals and for the monitoring of transplant recipients. Herein, we report results from a panel of 30 quantitative polymerase chain reaction (qPCR) assays for infectious agents with the potential to be transmitted to the human host. The reproducibility, sensitivity and specificity of each assay were evaluated and were found to exhibit analytic sensitivity that was similar to that of quantitative assays used to perform viral load testing of human viruses in clinical laboratories. This analytical approach was used to detect nucleic acids of infectious agents present in specimens from 9 sows and 22 piglets derived by caesarean section. The most commonly detected targets in adult animals were Mycoplasma species and two distinct herpesviruses, porcine lymphotrophic herpesvirus 2 and 3. A total of 14 piglets were derived from three sows infected with either or both herpesviruses, yet none tested positive for the viruses indicating that vertical transmission of these viruses is inefficient. Continued shortages of organs for transplantation have limited the number of transplants each year, and many patients die before organs become available. Transplantation of porcine organs has become an increasingly attractive approach as CRISPR/cas9 genome editing techniques have succeeded in reducing the rejection rate of transplanted organs. 1 Transmission of infectious disease during transplantation is always a concern, and allogenic transplantation is associated not only with the reactivation of opportunistic infections from the recipient, but also infectious agents present in the donor tissue that is transmitted to the immunosuppressed hosts. 2, 3 In the case of xenotransplantation, transmission of zoonotic infections, such as hepatitis E virus (HEV), or porcine infectious agents that might gain access to the human host during transplantation is an additional concern. 4,5 At present, the full spectrum of infectious agents with the potential for transmission to the human host, or that might produce pathology in transplanted porcine organs, has not been completely defined, but will improve over time. Going forward, ensuring the safety of these organs is of paramount importance, and the use of highly sensitive techniques to detect potential pathogens will help to minimize adverse events in xenotransplantation. The highly sensitive methods used for the detection of human viruses in transplant recipients have been applied to the detection of porcine viruses in pigs and has been recently reviewed. 6 Notable examples include the detection of porcine cytomegalovirus (PCMV) 7, 8 and hepatitis E virus (HEV) 9,10 using quantitative polymerase chain reaction (qPCR). The sensitivity and performance of these analytical methods appear to be comparable to those used in the clinical setting to detect opportunistic infections in human transplant recipients, and indeed, these assays promise to characterize porcine samples at a much more rigorous level than that used qualify tissues from human donors. 3 The studies described here are part of a larger effort to generate genetically engineered porcine organs for use in clinical trials to evaluate the potential of xenotransplantation. [11] [12] [13] Specifically, a set of 30 targets including viruses and Mycoplasma species was selected to include agents that have potential to impact the health of the graft tissue, or with the potential to be transmitted to humans during transplantation. Herein, we describe a diagnostic approach to detect a broad spectrum of infectious agents by adapting primer and probe sets reported in the literature to conform to a common amplification protocol on a common instrument. This new testing regimen was then utilized to detect each of the targets in 9 sows and 22 piglets derived by cesarean section. As many of the agents in this set are expected to be present in distinct tissues, blood, nasal swabs, and stool swabs were evaluated to enhance their detection. These data confirmed the presence of viruses that are endemic in the pig population in the United States, and this approach will be useful in helping to establish the frequency of many infections in herds. Finally, the data show that piglets derived by cesarean section were not infected with the same agents detected in the sows from which they were derived and are consistent with previous reports for herpesviruses. 14,15 To validate the infectious disease testing assays, a set of positive control plasmids was designed and synthesized to provide target sequences for each of the reactions. A description of sequences targeted by each of the assays is shown in Table S1 and includes the sequence of all the primers and probes, the accession numbers from cognate agents, and genomic coordinates. Each plasmid contains multiple targets as well as sequences for herpes simplex virus (HSV) to facilitate the absolute quantification of each plasmid by a validated assay in a clinical laboratory by established primers and methods. 16 Plasmids were synthesized, swine influenza (IFA), reovirus 1 (Reo1), reovirus 2 (Reo2), and rotavirus (Rota). Each of the plasmids was diluted to yield control solutions with a low copy number and were quantified in a clinical laboratory by a quantitative qPCR assay used to measure viral loads in clinical specimens. The absolute copy number of target DNA in each of the solutions was further adjusted such that the copy numbers of all the plasmids were equivalent and again experimentally confirmed by the HSV qPCR assay in the clinical laboratory. Finally, the control solutions were mixed in an equimolar ratio to produce a control solution that served as a quantitative control for all the targets described above. Where possible, qPCR assays reported in the literature were performed as reported, while others required adaptation to be compatible with the common testing platform used to facilitate parallel evaluation of all the targets on a QuantStudio 6 Flex instrument. Target sequences for the adapted assays were designed to be within the amplified regions reported in the literature or at least overlapped with the sequences identified in the references cited in Table 1 . Each of the primers and probes used in this study is shown in Table S1 together with the accession number of the nucleotide sequence used in the design of the primers and genomic coordinates for each target as well as the reference that formed the basis of the assay. All primers were obtained from a commercial supplier (Integrated DNA Technologies, Coralville IA), and probes were obtained NQ, Not a quantitative assay; NA, Not applicable as it is reported here for the first time. a Lower limit of detection (LLOD) is shown as copy number detected with a 95% frequency by Poisson analysis, or the concentration where fewer than 2 of 3 positive specimens were detected, whichever was greater. from the same suppliers with 5′ FAM fluorescent dye and both internal ZEN and 3′ Iowa Black quenchers. This analytical approach enables the parallel testing of all the targets at the same time and has the advantage of flexibility such that more targets can be detected by the addition of other primer and probe sets. to calculate the copy number using the standard formula log 10 (2 40-ct ). Additional controls include an internal control virus (influenza B virus, IFB) that is spiked into specimens from pigs to ensure that there were no interfering substances in the samples and that the reverse transcription and detection reactions were performing according to specifications. The internal control qPCR used to detect this control has been described previously and has been used to detect this virus in human clinical trials. 17 A control qPCR for porcine cyclophilin A sequences in genomic DNA was also included in each assay to ensure the integrity of the samples as a pre-analytic control. All the experiments were performed by methods prescribed in standard operating procedures in the laboratory to ensure the integrity of the analytical methods, and quality assurance measures confirmed the data from each experiment were valid. For the lower limit of detection studies, 11 2-fold dilutions of the control DNA were prepared and yielded concentrations that ranged from 10000 to 10 copies per reaction. The copy number of the diluted controls was then determined in 6 separate assays and Probit analysis was used to calculate the lowest copy number that could be detected with a frequency of 95% as a function of the variance of the experimental values. Data for the log 10 copy number of the control plasmids and the log 10 copy number of the experimentally determined data were entered into GraphPad Prism (La Jolla, CA) and best-fit equations, slopes, X-and Y-intercepts, R 2 coefficients, and the standard deviation of the residuals (Sy.x) were calculated. Probit analysis of the data was performed in excel to evaluate variance in the assay over a series of different control concentrations and was used to calculate the lower limit of detection (LLOD) defined as the copy number that could be detected in 95% of the assay reactions. For qualitative assays, the LLOD was defined as the lowest copy number at which positive signals were obtained in 5 of the 6 separate determinations. In a second set of studies, a separate dilution series of 300-0.6 copies was used to confirm results of the Probit analysis with the lower limit of detection defined as the lowest concentration at which 2 of 3 concentrations were positive. All Piglets were obtained by somatic cell nuclear transfer (SCNT) and were produced for research purposes. All the piglets were females, and their genetic background was Landrace x Yorkshire. Piglets were derived via caesarian section. Briefly, a 12-15 inches incision was made longitudinally in the ventromedial line, between the last teat and the umbilicus. After the abdominal cavity was accessed, the uterus was exposed, and a uterotomy incision was made along the uterine horns to remove all the fetuses. Alternatively, some litters were derived by doing a hysterectomy where the entire uterus was moved to a table and the piglets were harvested. Every piglet was extracted and handed to an assistant; the umbilical cord was clamped and dipped in 2.5% povidone-iodine, and any sign of abnormality was recorded. The newborns were then moved to a clean room dedicated to the piglets. Piglet's pens were equipped with supplemental lamps to heat the neonates. Piglets received a Mycoplasma + Circovirus vaccination when they were 3 weeks old. Piglets samples were taken at birth and then at euthanasia, when the animals were 1-14 days of age. Specimens evaluated in this study typically included blood, stool swabs, and nasal swabs, but varied depending on when they were harvested. Swabs containing nasal and stool specimens were added to standard viral transport media (VTM) supplemented with nystatin and gentamycin and mixed at a 1:1 ratio with RNAlater (Invitrogen, Carlsbad, CA). For blood specimens, material was collected in PAXgene blood RNA tubes (Thermo Fisher Scientific, Waltham, MA). All samples were frozen at −20°C prior to transfer to the laboratory for further analysis. Whole blood in PAXgene tubes was inverted to mix and stored at 4°C until shipment. Once received in the laboratory, all samples were logged in and stored at −80°C. Deidentified human specimens testing as positive for human viruses were obtained from the University of Alabama at Birmingham, Department of Pediatrics Molecular Diagnostic Laboratory. Specimen types included swabs from skin, whole blood, and plasma. to 70°C for 10 minutes, and then, nucleic acids were extracted by the same methods used for nasal samples. For blood specimens, total nucleic acids were extracted using an EZ1 Virus Mini v2.0 kit and the EZ1 BioRobot. The procedure was essentially the same as for nasal specimens, but the blood specimen was suspended in buffer ATL and vortexed prior to extraction on the instrument. The overall goal of these studies was to assess specimens from sows and piglets derived by cesarean sections for infectious agents to help understand the rate of infection in these cohorts and potential transmission of viruses from sows to their piglets. Initial objectives focused on the characterization of each assay to establish reproducibility, sensitivity, and specificity as well as establish the lower limit of detection to help compare results presented here with those from other laboratories. Additional studies examined different sample types from the same animals to help understand the most efficient way to detect each of the infectious agents tested. Finally, a set of piglets derived by cesarean section were evaluated to compare their rate of infection with that from the sows from which they were derived. The adaptation of primer and probe sets reported in the literature to this common platform was achieved by increasing or decreasing the length of oligonucleotides used as primers and probes, while targeting or overlapping the same amplified region in the reports. This approach resulted in assays that were very similar in their performance characteristics and is evident in the similarity in the assay performance parameters summarized in Table 1 . Initial studies for assays for all of the agents listed in Table 1 established the LLOD by evaluating a series of control DNAs at a known copy number to assess the sensitivity of the assays. Experimental results were compared to the input copy number using statistical methods to calculate a best-fit line to assess the linearity and sensitivity of each assay. A summary of the performance of each assay is provided in Table 1 including the slope, R 2 coefficients, standard deviation of the residuals, LLOD, and a reference for each analytical assay. The data are also summarized in Figure 1 to illustrate the dynamic range, linearity, and reproducibility of each assay. Most of the assays shared similar performance characteristics, and all but 3 appeared to exhibit features of good quantitative assays. Salient features of the assays are as follows: i) each was highly reproducible with standard deviation values that were on average ±0.2 log 10 copies for all concentrations of the plasmids, ii) all assays were highly sensitive, iii) most yielded data that were quantitative with slopes that ranged between 0.56 and 0.91 with R 2 coefficients that ranged between 0.73 and 0.94 and corresponded to standard deviation of residual values of 0.13-0.54, iv) assays that did not prove to be quantitative were Noro, WNV, and Rota, and v) all of the quantitative assays exhibited LLOD values of between 1 and 16 copies as defined by copy number that could be detected with a frequency of 95% calculated by Probit analysis. To confirm this high level of sensitivity, a second lower set of control plasmid dilutions was prepared, and two of three assays detected cognate sequences in assays that included from 1 to 4 copies of all targets, except LCMV in which 2 of 3 specimens were detected for 10 copies (data not presented). For qualitative assays, the LLOD was defined as the lowest concentration at which 5 of 6 samples tested positive ( Table 1 ). The LLOD of every one of the quantitative assays was between 1 and 16 copies per assay, which is similar to the sensitivity of the validated HSV assay that is used for clinical specimens and was used to document the concentration of the control plasmids. 16 Further, the sensitivity of the HSV assay was also determined on this platform and was used to confirm the accuracy of LLOD estimates. The LLOD of this control assay was nearly identical to the sensitivity determined in clinical laboratory that validated the plasmid control solutions and provides assurance that the assay platform was performing as designed (data not presented). Finally, while assays for Noro, WNV, and Rota were highly sensitive, they did not appear to yield good quantitative data as indicated by the low R 2 coefficients and aberrant slope values (Table 1) . Ongoing efforts in the laboratory are evaluating new primer sets with the hope of improving these assays and adding additional targets. As expected, most of the assays (28/31) exhibited excellent linearity and yielded high-quality quantitative data ( Figure 1 , Table 1 ). Additionally, they were highly reproducible as is apparent in the error bars shown in figure 1. Three assays, WNV, Rota, and Noro, were highly sensitive but yielded low slope values and elevated standard deviations of the residual values indicating that the assays would not generate high-quality quantitative data and thus are considered to be qualitative assays (See Figure 1A, Table 2 ). The only target detected in this analysis was obtained for the porcine cyclophilin A gene used to detect host DNA as a pre-analytical control for sample integrity and was expected given the high level of conservation between the pig and human genes. For this target, only three nucleotides in the 77 base pair target sequence were different between the porcine and human genes. Also, as the nucleic acids were prepared in the clinical laboratory, the samples were not spiked with influenza B virus, and as a consequence, the IFB controls were also negative as expected. Notably, none of the assays for porcine viruses detected any of the viruses in the human specimens. For instance, the primers for the porcine herpesviruses PCMV, PLHV1, PLHV2, and PLHV3 did not amplify any of the human herpesvirus sequences in the specimens including HSV, HCMV, VZV, EBV, or HHV6 even though two of the specimens tested contained more than 10 9 and 10 7 copies/ml of VZV and HSV, respectively. These data confirmed that the assays are highly specific and do not appear to cross-react with many of the infections that might be expected to occur in human subjects. F I G U R E 1 Sensitivity and linearity of qPCR assays. A set of plasmids containing each of the target nucleic acid sequences was subjected to a set of 2-fold dilutions to yield the absolute copy number shown on the horizontal axis of each XY plot. Each dilution was quantified in six separate experiments, and the average copy number was calculated and shown on the vertical axis of each plot with error bars representing the standard deviation values. Most assays yielded linear relationships with low standard deviation values and slopes approaching 1.0; however, some of the assays did not perform to a level required for quantitative assays including WNV, Noro, and Rota in panels A, E, and F, respectively. The assays for these three viruses did prove to be highly sensitive and are good qualitative assays. While most of the assays yielded similar amplification characteristics, differences in the specific amplification efficiencies can contribute to differences in both the slope and Y-intercept for some of the assays 3.4 - - 1.3 2.1 - - - - - - - - - - - 3.2 - - - 1.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.7 - - - - - - - - - - - - - - - - - - - - 2.0 c - - 0.6 c - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - 1.5 2.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - (Continues) The validated assays described above were used to assess blood, nasal, stool, or tissue specimens from a set of 9 adult animals and 22 piglets derived by caesarian section, and all data are presented together in Table 3 . Overall, studies performed well and detected a single or small number of specific targets in some animals, while no signals were detected in assays for most of the other targets. This is consistent with the high specificity of the assays described above. Of the specimens from adult animals, 3/9 were negative for every viral infection (without regard to PERV-C status), and two animals were negative for all viral and mycoplasma targets. No infections with influenza, rotavirus, parvovirus, or circovirus 2 were observed and were expected as the herd was vaccinated against these viruses and is also consistent with the data suggesting these are highly specific assays. The most common targets detected were the haemotropic were generally negative. In this study, all the MycoF-positive samples were from stool or nasal specimens and were not detected in blood specimens from the same animals. These results confirm that the assays for these two groups of mycoplasma are highly specific and suggest that the different groups of haemotropic mycoplasma species have a distinct tissue tropism. 18 It is unsurprising that many of the animals were infected with mycoplasma species as infections with Mycoplasma hyopneumoniae and related species are very common infections in pigs. 19 The gammaherpesviruses were the most frequently detected viruses in the adult animals, and both PLHV3 (5/9) and PLHV2 (3/9) were observed. Two of the animals were positive for both of these viruses. Of the 9 specimens testing positive for a gamma herpesvirus, only 2 specimens were positive for both PLHV3 and PLHV2 and indicate that the assays are specific and can distinguish between these viruses. DNA from these viruses was most often detected in blood or nasal, although one stool specimen tested positive for PLHV3 in an animal that also had a positive signal from a blood specimen. This result was largely expected as these infections are frequently detected in both feral and domestic hogs in many geographic regions. 20, 21 The assays described here can detect the coronaviruses PHEV, TGEV, and the closely related virus porcine respiratory coronavirus (PRCV), as well as porcine epidemic diarrhea virus (PEDV). [22] [23] [24] Specimens tested from the animals described above were all obtained during the summer months, and none of them tested positive for any of these viruses. However, PHEV was detected in other adult animals from specimens obtained during the winter respiratory season (data not presented) and was not unexpected as it is frequently detected in domestic animals in the US. 25 The assay for PERV-C detected target sequences in 3/9 adult animals. Positive specimens included blood, nasal, and stool samples. In two animals, levels of PERV-C were within 1-2 orders of magnitude of the PCYP control and might indicate that the assay was detecting integrated PERV-C sequences. But in the third animal, PERV-C levels detected were very low and >4 orders of magnitude lower than the PCYP control. In contrast to results with the adult animals, most of the 22 piglets delivered by caesarian section were negative for all the targets tested with the exception of a single positive nasal specimen that was positive for the Mycoplasma haemofelis group (Table 3) . This result is consistent with results from adult animals where this target is detected most often stool and nasal specimens. One notable result was that three separate sets of piglets were derived from sows in which PLHV2 was detected, yet none of the piglets appeared to be infected with this virus. One of the sows was also infected with PLHV3, yet did not appear to transmit either virus to any of 7 piglets delivered by caesarian section. These results confirmed that the vertical transmission of these agents is inefficient as has been confirmed by others 14, 15 and also that procedures used to derive these piglets could also minimize transmission of these viruses. A single animal (Table 3 , piglet B1) yielded positive results for three separate viruses including influenza A virus, reovirus 1, and rotavirus. This result triggered an investigation as the coinfection with three viral agents was very unusual. When this specimen was reextracted and repeated, these targets were not detected and were determined to be false positives. Results from the testing of all 54 pig specimens indicated that the assays performed well and typically detected a small number of target nucleic acids as expected. It also showed that piglets derived by caesarian section were typically negative for targets detected in the sows from which they were derived. These data are consistent with the high specificity observed with these assays, and typically, a single or small number of specific targets was de- The overarching goal of these studies was to provide a wellcharacterized set of assays for the detection of virus nucleic acids to help ensure the microbiological safety of the organs for research purposes as well as monitoring potential transmission of these agents to transplantation recipients. The list of viruses tested was determined in a separate effort that identified agents which may occur in our local geographic range at more than a nil rate with a host range extending to both humans and pigs, or that reside on the list of viruses applicable to swine in 9 CFR §113.47. The assays described hold promise as part of screening program to identify suitable donor animals, validate and release of transplantable organs for research purposes, and monitor transplant recipients; the frequency of testing and the specific specimens tested will obviously vary depending on specific needs, but the molecular assays will remain the same. The testing approach described here is similar to the comprehensive microbiological safety approach for agarose encapsulated RabV Reo 1 Reo 2 Reo 3 Rota Sapo SVA TGEV WNV ------------- The analytical approach presented here continues to be used to - - - 4.2 - - - 2.6 - - - - - - - - - - - 2.4 - - - 1.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.9 - - - - - - - - - - - - - - - 1.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - The most common infectious agents detected in data presented here were species in the haemotropic mycoplasma groups, and only 3/9 adult animals tested negative in all sample types. The assays reported previously for the two major groups of mycoplasma also appeared to be highly specific with some animals infected with either one or the other of the two groups of mycoplasma. 18 It was interesting that mycoplasma haemominutum group was only detected in a blood specimen, while those in the mycoplasma haemofelis group were detected only in nasal and stool specimens and also confirms the specificity of this assay. It was unsurprising that many of the animals were infected with mycoplasma species as infections with Mycoplasma hypopneumoniae and related species are very common infections in pigs. 19 The gammaherpesviruses were the most frequently detected viruses in the sows, and both PLHV3 (3/9) and PLHV2 (5/9) were observed. DNA from PLHV2 was detected in blood and nasal specimens including one animal that had a positive signal from both blood and nasal specimens. Of the 3 animals infected with PLHV3, one animal was positive in blood and nasal, a second was positive in blood, and the third animal was positive in both blood and stool. In total, 18 specimens were tested from these animals and only two were positive for both viruses suggesting that this assay can distinguish between these viruses and is also consistent with the high specificity described for these assays in Table 2 The analytical approach described here evaluates infections with assays that can detect four coronaviruses and is important because many coronaviruses can cross species barriers readily and can cause zoonotic infections. 37 The target for swine hepatitis E was not detected in any specimen notwithstanding the use of an assay reported to be highly sensitive for this virus. 39 Swine hepatitis E virus has the potential to infect humans and is described in an excellent recent review. 40 Going forward, it will be critical to monitor both sows and particularly piglets to ensure that transplanted tissue remain free of the virus. 41 The studies presented here were limited by the availability of pig specimens that tested positive in other laboratories for each of the infectious agents described here. It is also limited by the relatively small number of animals we described in detail in this report. However, the subsequent evaluation of more than 300 additional specimens has resulted in the detection of most of the targets including SVA, Noro, IFA, REO1, PHEV, PLHV1, PLHV2, PLHV3, PRRS, Rota, PCV1, PCV2, BVDV, PCMV, PADV, MycoF, MycoM, PERV-C, P-CYP, and specimens spiked with the EMCV. The detection of these targets in pig specimens provides reassurance that the analytical methods are functioning as designed, and there is no a priori reason why some targets might be more difficult to detect than others with the methods described here. Importantly, these data and the data in Table 3 also help document the analytical specificity of each of the assays in the infectious disease panel for porcine specimens; each specimen is evaluated with 30 separate assays for different viruses in parallel so the detection of one positive target typically occurs together with negative results for the remaining 29 targets. Ideally, the assay validation process would be similar to that used for assays for human viruses that are in clinical use and have been described in reports of clinical trials. 17, 42 Continued efforts to evaluate large numbers of porcine specimens is expected to yield positive samples for most of these targets and will be valuable reagents as validation studies continue. The sensitivities of the assays described here compare favorably with the sensitivities described for other similar assays described by others. 26 For PCMV, the sensitivity of 1 copy/reaction reported here is similar to that of 2 copies/reaction reported previously, 43 and for HEV, the sensitivity of 3 copies/reaction reported here is similar to the 4-10 genomic equivalents/reaction reported previously. 39 While the sensitivities of qPCR assays used in many different laboratories are likely to be similar, the adoption of international standards by World Health Organization would help to make more direct comparisons possible in the future. Nonetheless, the high sensitivity and analytical specificity of the assays described here suggest that they perform at least as well as those described in previous reports discussed above. The assays we describe here were selected and designed to provide the parallel evaluation of a comparatively large set of targets that were selected to help minimize the risk of disease transmission in the xenotransplantation setting. As this assay is largely automated, it is possible for an individual to evaluate at least 30 specimens per day with this panel, and the assays could also be easily multiplexed by the addition of different fluorescent labels to the probes or coded sequences to the primers. The flexibility that this approach affords will be important moving forward as information on potential risks improves, and more targets are added to the set of agents described in this work. Nonetheless, the panel reported herein promises to provide data to enhance the safety of porcine tissues for xenotransplantation and will also be valuable in the evaluation of human specimens following xenotransplantation. This project was funded in part with funds from the UAB Department of Pediatrics (MNP) and National Institutes of Health grant 5R01AI126322-02 (to AJT). Parts of the project were funded by United Therapeutics. Joe Tector holds patents in the fields of pig engineering and xenotransplantation. He has also founded the company Xenobridge llc. Mark N. Prichard http://orcid.org/0000-0002-2720-6661 The resurgence of xenotransplantation Infection in solid-organ transplant recipients Assessment of infectious risk in clinical xenotransplantation: the lessons for clinical allotransplantation Xenotransplantation -a special case of one health Emerging and re-emerging swine viruses Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses Effective detection of porcine cytomegalovirus using non-invasively taken samples from piglets Extended microbiological characterization of Gottingen minipigs: porcine cytomegalovirus and other viruses Extended microbiological characterization of gottingen minipigs in the context of xenotransplantation: detection and vertical transmission of hepatitis E virus Comparison of real-time reverse transcriptase PCR assays for detection of swine hepatitis E virus in fecal samples Recent advances in genome editing and creation of genetically modified pigs Evaluation of human and nonhuman primate antibody binding to pig cells lacking GGTA1/CMAH/ beta4GalNT2 genes Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease Methods for the exclusion of circoviruses and gammaherpesviruses from pigs Porcine cytomegalovirus in pigs being bred for xenograft organs: progress towards control Detection of Herpes simplex virus DNA by real-time PCR Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza Investigation of human haemotropic Mycoplasma infections using a novel generic haemoplasma qPCR assay on blood samples and blood smears Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection A novel porcine gammaherpesvirus Infection of pigs in Ireland with lymphotropic gamma-herpesviruses and relationship to postweaning multisystemic wasting syndrome Multiplex real-time RT-PCR for the simultaneous detection and quantification of transmissible gastroenteritis virus and porcine epidemic diarrhea virus Porcine respiratory coronavirus differs from transmissible gastroenteritis virus by a few genomic deletions In vitro inhibition of porcine hemagglutinating encephalomyelitis virus replication with siRNAs targeting the spike glycoprotein and replicase polyprotein genes Porcine hemagglutinating encephalomyelitis virus and respiratory disease in exhibition swine A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand Epstein-Barr virus-recent advances Xenotransplantation and porcine cytomegalovirus Genomic organization and molecular characterization of porcine cytomegalovirus Xenotransplantation and the potential risk of xenogeneic transmission of porcine viruses Experimental transplacental transmission of porcine cytomegalovirus Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7) Herpesviruses-a zoonotic threat? Evaluation of porcine cytomegalovirus as a potential zoonotic agent in xenotransplantation Human fibroblasts are permissive for porcine cytomegalovirus in vitro SARS and MERS: recent insights into emerging coronaviruses A small region of porcine hemagglutinating encephalomyelitis virus spike protein interacts with the neural cell adhesion molecule A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus Hepatitis E virus: animal reservoirs and zoonotic risk Swine hepatitis E virus: cross-species infection and risk in xenotransplantation Valganciclovir for symptomatic congenital cytomegalovirus disease New PCR diagnostic systems for the detection and quantification of porcine cytomegalovirus (PCMV) Real-time reverse transcription PCR detection of norovirus, sapovirus and astrovirus as causative agents of acute viral gastroenteritis A one-step multiplex real-time RT-PCR for detection and typing of bovine viral diarrhea viruses Chikungunya virus in US travelers returning from India Development of a TaqMan-based real-time reverse transcription polymerase chain reaction assay for the detection of encephalomyocarditis virus Development of a realtime reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo Diagnosis of viral gastroenteritis by simultaneous detection of Adenovirus group F, Astrovirus, Rotavirus group A, Norovirus genogroups I and II, and Sapovirus in two internally controlled multiplex real-time PCR assays Development of a qPCR assay for the quantification of porcine adenoviruses as an MST tool for swine fecal contamination in the environment Porcine cytomegalovirus infection is associated with early rejection of kidney grafts in a pig to baboon xenotransplantation model Replication of porcine circovirus type 1 requires two proteins encoded by the viral rep gene Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs Detection of porcine parvovirus using a taqman-based real-time pcr with primers and probe designed for the NS1 gene Simultaneous detection of North American and European porcine reproductive and respiratory syndrome virus using realtime quantitative reverse transcriptase-PCR Development of a TaqMan real-time RT-PCR assay for the detection of rabies virus Development of an integrated cell culture-real-time RT-PCR assay for detection of reovirus in biosolids Sensitive detection of multiple rotavirus genotypes with a single reverse transcription-real-time quantitative PCR assay Real-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay Additional supporting information may be found online in the Supporting Information section at the end of the article.